Clinical trial

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

NCT02908347

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MP1032 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE2

Conditions

Psoriasisverified · MONDO: psoriasis

Plaque Psoriasisunresolved

Interventions

MP1032DRUG

PlaceboDRUG

Sponsors & collaborators

MetrioPharm AGlead sponsor

Parexelcollaborator

Mapped research locations

BerlinGermany2 DresdenGermany1 Freiburg im BreisgauGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02908347 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.